Park Ha Biological Technology Co., Ltd.
PHH · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,382 | $2,459 | $1,919 | $931 |
| % Growth | -3.1% | 28.1% | 106.2% | – |
| Cost of Goods Sold | $195 | $311 | $509 | $311 |
| Gross Profit | $2,187 | $2,148 | $1,410 | $620 |
| % Margin | 91.8% | 87.4% | 73.5% | 66.6% |
| R&D Expenses | $37 | $31 | $61 | $0 |
| G&A Expenses | $815 | $485 | $707 | $752 |
| SG&A Expenses | $1,176 | $785 | $1,146 | $1,121 |
| Sales & Mktg Exp. | $361 | $300 | $439 | $369 |
| Other Operating Expenses | $180 | $152 | $6 | $0 |
| Operating Expenses | $1,393 | $968 | $1,213 | $1,121 |
| Operating Income | $794 | $1,181 | $197 | -$501 |
| % Margin | 33.3% | 48% | 10.3% | -53.8% |
| Other Income/Exp. Net | -$0 | $1 | -$7 | $16 |
| Pre-Tax Income | $793 | $1,182 | $190 | -$485 |
| Tax Expense | $315 | $330 | -$1 | $0 |
| Net Income | $479 | $852 | $191 | -$485 |
| % Margin | 20.1% | 34.6% | 10% | -52.1% |
| EPS | 0.018 | 0.033 | 0.007 | -0.019 |
| % Growth | -43.7% | 345.2% | 139.5% | – |
| EPS Diluted | 0.018 | 0.033 | 0.007 | -0.019 |
| Weighted Avg Shares Out | 26,200 | 26,200 | 26,200 | 26,200 |
| Weighted Avg Shares Out Dil | 26,200 | 26,200 | 26,200 | 26,200 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $23 | $20 | $30 | $39 |
| EBITDA | $816 | $1,201 | $221 | -$445 |
| % Margin | 34.3% | 48.8% | 11.5% | -47.8% |